Drugs / DR-3001
last change Mar 2010 re-read 3 minutes ago

DR-3001

Developed for
overactive bladder
Investigated by
Duramed Research

Trials 2

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT00196404 Oct 2004 → Dec 2006 overactive bladder Duramed Research Completed No outcome recorded
Phase 31 trial
Phase 3 NCT00685113 May 2008 → Mar 2010 overactive bladder Duramed Research Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as DR-3001 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00685113 ↗
1

NCT00196404 ↗